Abstract
Invasive fungal infections (IFI) are a common cause of life-threatening events in immunocompromised patients. Early detection and identification of the fungal pathogen is an important prerequisite for timely onset of the most appropriate treatment. Methods based on fungal culture are often too slow to be clinically useful. Other approaches to the identification of fungal species, including molecular techniques, are often restricted to a small number of the most commonly occurring pathogens and are therefore of limited use in the clinical setting. The development of assays for the detection and identification of a broad-range of clinically relevant fungal species is therefore an urgently needed step towards optimized diagnostics of IFI.
The Luminex® xMAP technology offers a platform for the establishment of multiplex assays permitting high-throughput analysis of up to 100 different target molecules in a single test. Here we describe a Luminex®-based multiplex assay permitting rapid detection and identification of 10 fungal genera and 29 different species, including both commonly occurring and emerging fungal pathogens.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Walsh TJ et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360
Richardson M, Lass-Florl C (2008) Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14(Suppl 4):5–24
Cornely OA (2008) Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 36:296–313
Caston-Osorio JJ et al (2008) Epidemiology of invasive fungal infection. Int J Antimicrob Agents 32(Suppl 2):S103–S109
Lass-Florl C (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52:197–205
Malani AN, Kauffman CA (2007) Changing epidemiology of rare mould infections: implications for therapy. Drugs 67:1803–1812
Marr KA et al (2002) Aspergillosis, pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 16:875–894, vi
Morace G, Borghi E (2010) Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 76: 950–956
Lau A et al (2007) Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 45:380–385
Leaw SN et al (2006) Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44:693–699
Landlinger C et al (2008) Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis 28(6):613–622
Gharizadeh B et al (2004) Identification of medically important fungi by the Pyrosequencing technology. Mycoses 47:29–33
Montero CI et al (2008) Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur J Clin Microbiol Infect Dis 27:821–830
Leinberger DM et al (2005) Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol 43:4943–4953
Spiess B et al (2007) DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 45:3743–3753
Das S et al (2006) DNA probes for the rapid identification of medically important Candida species using a multianalyte profiling system. FEMS Immunol Med Microbiol 46: 244–250
Diaz MR, Fell JW (2004) High-throughput detection of pathogenic yeasts of the genus trichosporon. J Clin Microbiol 42:3696–3706
Zeng X et al (2007) Reverse line blot hybridization assay for identification of medically important fungi from culture and clinical specimens. J Clin Microbiol 45:2872–2880
Landlinger C et al (2009) Species-specific identification of a wide range of clinically relevant fungal pathogens by the Luminex xMAP™ technology. J Clin Microbiol 47(4):1063–1073
Landlinger C et al (2010) Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia 24:2032–2038
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Preuner, S., Lion, T. (2013). Species-Specific Identification of a Wide Range of Clinically Relevant Fungal Pathogens by the Luminex® xMAP Technology. In: O'Connor, L., Glynn, B. (eds) Fungal Diagnostics. Methods in Molecular Biology, vol 968. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-257-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-257-5_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-256-8
Online ISBN: 978-1-62703-257-5
eBook Packages: Springer Protocols